Actionable news
0
All posts from Actionable news
Actionable news in AGEN: Agenus Inc.,

Agenus to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

LEXINGTON, Mass., Sept. 6, 2016 /PRNewswire/ -- Agenus Inc. (AGEN), an immuno-oncology (I-O) company developing antibodies, including checkpoint inhibitors and other checkpoint modulators, and cancer vaccines, today announced that the Company will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12th at 2:10 p.m. Eastern Time. The conference will take place at the Lotte New York Palace Hotel in New York City.

The live and archived webcast of the presentation will be accessible from the Company's website at www.agenusbio.com/webcast. Please log in approximately 5-10 minutes before the event to ensure a timely connection. A replay will be available on the Company's website approximately two hours after the call and will remain available for 60 days.

Agenus is an immuno-oncology company focused on the discovery and development of...


More